Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with CirrhosisNagisa Hara, Yoshiyuki Takei, Masumi Ishidome et al.|Internal Medicine|2016Cited by 114
Changes in liver function and body composition by direct‐acting antiviral therapy for hepatitis C virus infectionRyosuke Sugimoto, Yoshiyuki Takei, Kyoko Yoshikawa et al.|Hepatology Research|2017Cited by 31
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Yoshiyuki Takei, Ryosuke Sugimoto et al.|Metabolic Brain Disease|2016Cited by 28
Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseasesKyoko Yoshikawa, Yoshiyuki Takei, Motoh Iwasa et al.|Hepatology Communications|2017Cited by 27
Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular CarcinomaMotoh Iwasa, Yoshiyuki Takei, Ryosuke Sugimoto et al.|Journal of Nutritional Science and Vitaminology|2015Cited by 17